Estrogen receptor (ER), Ki-67, p27Kip1, and histologic grade as predictors of pathologic complete response (pCR) in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy (NAC) using fluorouracil, epirubicin, and cyclophosphamide (FEC), taxanes, and trastuzumab.
Sasagu Kurozumi
No relevant relationships to disclose
Kenichi Inoue
No relevant relationships to disclose
Hiroyuki Takei
No relevant relationships to disclose
Hiroshi Matsumoto
No relevant relationships to disclose
Takashi Yoshida
No relevant relationships to disclose
Yuji Hayashi
No relevant relationships to disclose
Jun Ninomiya
No relevant relationships to disclose
Kazuyuki Kubo
No relevant relationships to disclose
Shigenori E Nagai
No relevant relationships to disclose
Hanako Oba
No relevant relationships to disclose
Masafumi Kurosumi
No relevant relationships to disclose
Toshio Tabei
No relevant relationships to disclose
Jun Horiguchi
No relevant relationships to disclose
Izumi Takeyoshi
No relevant relationships to disclose